Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
“A meta-analysis of RCTs of men with T2DM and/or the metabolic syndrome found no evidence of an improvement in HbA1c (141).”
InfluentialKapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
“Epidemiological studies have consistently reported that up to 40% of men with T2DM have testosterone deficiency (Dhindsa et al .”
BackgroundCancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548
“In men with type 2 diabetes, low testosterone is associated with a high prevalence of symptomatic hypogonadism (3), frequently due to hypogonadotrophic hypogonadism (5).”
BackgroundClinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Kapoor, D., Aldred, H., Clark, S., Channer, K. S., & Jones, T. H. (2007) · Diabetes Care · doi:10.2337/dc06-1426 · Cited by 493
“(9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
BackgroundInfluentialLow testosterone levels are common and associated with insulin resistance in men with diabetes
Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2177 · Cited by 468
“Testosterone deficiency is common in men with type 2 diabetes (1) in whom it may contribute to impaired performance,”
BackgroundResultErectile Dysfunction in Diabetes Mellitus
Malavige, L. S., & Levy, J. C. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01168.x · Cited by 444
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414
The role of androgens and estrogens on healthy aging and longevity
Horstman, A. M., Dillon, E. L., Urban, R. J., & Sheffield-Moore, M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls068 · Cited by 396
Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K. S., & Jones, T. H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0321 · Cited by 389
Type 2 diabetes mellitus and testosterone: a meta-analysis study: Type 2 diabetes and testosterone
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Sforza, A., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01117.x · Cited by 370
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Lega, I. C., & Lipscombe, L. L. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz014 · Cited by 364
“Explanations for the reverse association between diabetes and cancer include reduced circulating androgen levels (173) and PSA levels (174) among patients with diabetes.”
Testosterone concentrations in diabetic and nondiabetic obese men
Dhindsa, S., Miller, M. G., McWhirter, C. L., Mager, D. E., Ghanim, H., Chaudhuri, A., & Dandona, P. (2010) · Diabetes Care · doi:10.2337/dc09-1649 · Cited by 352
“The hypotheses tested were that (1) the obese have a higher prevalence of subnormal FT concentrations than the non-obese and (2)”
BackgroundInfluentialSelf-citationTestosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 352
“Study findings indicate, therefore, that the state of insulin resistance, hyperglycemia and/or the metabolic syndrome can cause a special form of mild secondary hypogonadism, or, most likely, promote late-onset hypogonadism as a mixed form of primary and secondary androgen deficiency ( Figure 1 )”
BackgroundLow Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350
“These studies from Australia (9), the United Kingdom (10), and the United States (11) consistently showed that 30–50% of aging, obese men with diabetes, in the absence of known testicular or pituitary pathology, have low total or free testosterone, at least relative to reference ranges based on healthy young men.”
BackgroundInfluentialDiabetes and sexual dysfunction: current perspectives
Esposito, K., Maiorino, M. I., & Bellastella, G. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s36455 · Cited by 342
“Subnormal testosterone concentrations have been found in 25% of men with type 2 diabetes in association with inappropriately low luteinizing hormone (LH) and folliclestimulating hormone (FSH) concentrations.(67,68) Testosterone regulates nearly every component of erectile function, from pelvic ganglions to smooth musc…”
Basaria, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61126-5 · Cited by 328
Androgens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
“A recent study in 103 type 2 diabetic men showed the prevalence of hypogonadism to be 33% based on assessment of free testosterone by the equilibrium dialysis method.([20])”
MethodUpdate: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona, P., & Dhindsa, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2724 · Cited by 313
Self-citationThe Metabolic Syndrome and Male Infertility
Kasturi, S. S., Tannir, J., & Brannigan, R. E. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.003731 · Cited by 308
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292
Dhindsa, S., Ghanim, H., Batra, M., Kuhadiya, N. D., Abuaysheh, S., Sandhu, S., Green, K., Makdissi, A., Hejna, J., Chaudhuri, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1518 · Cited by 286
“The first report of frequent occurrence of subnormal free testosterone concentrations in males with type 2 diabetes demonstrated that while the duration of diabetes or the quality of its control had no relationship with plasma testosterone concentrations, the latter were inversely related to BMI (1,2).”
BackgroundSelf-citationTestosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle
White, J. P., Gao, S., Puppa, M. J., Sato, S., Welle, S. L., & Carson, J. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.019 · Cited by 251
“All rights reserved. uth Carolina, Department of 1 Assembly St., Room 405, 0809 (O), +1 803 777 0142 et al., 2005), cancer (Vigano et al., 2010), and type 2 diabetes (Dhindsa et al., 2004).”
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish, A. M., Saad, F., & Guay, A. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005751 · Cited by 266
Kenny, A. M., Kleppinger, A., Annis, K., Rathier, M., Browner, B., Judge, J. O., & McGee, D. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02865.x · Cited by 252
“7%.(28,29) In the population of frail men in the current study, selected for osteoporosis, all but one met the cutoff for low testosterone (defined as total or bioavailable testosterone 1.”
BackgroundDihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels
Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1067 · Cited by 237
“In addition, l w T is a risk factor for the development of diabetes and associated cardiovascular sequel [165-167].”
Kapoor, D., Clarke, S., Stanworth, R., Channer, K. S., & Jones, T. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0737 · Cited by 234
Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00951.x · Cited by 223
Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature
Oskui, P. M., French, W. J., Herring, M. J., Mayeda, G. S., Burstein, S., & Kloner, R. A. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000272 · Cited by 223
Endocrine Aspects of Male Sexual Dysfunctions
Buvat, J., Maggi, M., Gooren, L., Guay, A. T., Kaufman, J., Morgentaler, A., Schulman, C., Tan, H. M., Torres, L. O., Yassin, A., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01780.x · Cited by 221
A practical guide to male hypogonadism in the primary care setting
Dandona, P., & Rosenberg, M. T. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02355.x · Cited by 219
Self-citationSex differences in micro- and macro-vascular complications of diabetes mellitus
Maric-Bilkan, C. (2017) · Clinical Science · doi:10.1042/cs20160998 · Cited by 217
Testosterone Therapy and Cardiovascular Risk: Advances and Controversies
Morgentaler, A., Miner, M. M., Caliber, M., Guay, A. T., Khera, M., & Traish, A. M. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.011 · Cited by 210
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 210
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Bansal, D., Bhansali, A., Kapil, G., Undela, K., & Tiwari, P. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.40 · Cited by 206
Testosterone for the aging male; current evidence and recommended practice
Jones, H. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s190 · Cited by 204
“A study of patients with type 2 diabetes using measurement of serum free testosterone by the gold standard method of equilibrium dialysis, found a 33% prevalence of biochemical hypogonadism (Dhindsa et al 2004).”
Obesity and Male Reproductive Potential
Hammoud, A. O., Gibson, M., Peterson, C. M., Hamilton, B. D., & Carrell, D. T. (2006) · Journal of Andrology · doi:10.2164/jandrol.106.000125 · Cited by 202
Testosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 194
Corona, G., Mannucci, E., Petrone, L., Ricca, V, Balercia, G., Mansani, R., Chiarini, V, Giommi, R., Forti, G., & Maggi, M. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901391 · Cited by 189
Kaplan, S. A., Meehan, A. G., & Shah, A. (2006) · Journal of Urology · doi:10.1016/j.juro.2006.06.003 · Cited by 185
Traish, A. M., Haider, A., Doros, G., & Saad, F. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12319 · Cited by 186
Diabetes, Sarcopenia, and Frailty
Morley, J. E. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2008.03.004 · Cited by 186
“Men who have diabetes have lower testosterone and bioavailable testosterone levels than do nondiabetic men [44,45].”
BackgroundHackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., & Wilkinson, P. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12146 · Cited by 182
Androgen deficiency, diabetes, and the metabolic syndrome in men
Kalyani, R. R., & Dobs, A. S. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32814db856 · Cited by 177
The role of testosterone in erectile dysfunction
Corona, G., & Maggi, M. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2009.235 · Cited by 172
Noto, H., Tsujimoto, T., Sasazuki, T., & Noda, M. (2011) · Endocrine Practice · doi:10.4158/ep10357.ra · Cited by 168
Hackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., Wilkinson, P., & the BLAST Study Group (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12404 · Cited by 168
Gianatti, E. J., Dupuis, P., Hoermann, R., Strauss, B. J., Wentworth, J. M., Zajac, J. D., & Grossmann, M. (2014) · Diabetes Care · doi:10.2337/dc13-2845 · Cited by 168
“001) and increased lean mass (MAD 2,078 g [1,519–2,637]; P, 0.”
Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
Corradi, P. F., Corradi, R. B., & Greene, L. W. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.001 · Cited by 187
Saad, F., Haider, A., Doros, G., & Traish, A. (2013) · Obesity · doi:10.1002/oby.20407 · Cited by 165
Yassin, A., Haider, A., Haider, K. S., Caliber, M., Doros, G., Saad, F., & Garvey, W. T. (2019) · Diabetes Care · doi:10.2337/dc18-2388 · Cited by 164
“glycemic control, duration of disease, and obesity, was published in 2004 (4).”
BackgroundHypogonadotropic Hypogonadism in Men With Diabesity
Dhindsa, S., Ghanim, H., Batra, M., & Dandona, P. (2018) · Diabetes Care · doi:10.2337/dc17-2510 · Cited by 158
“(LH) and follicle-stimulating hormone (FSH) concentrations in men with type 2 diabetes were first described by us in 2004 (1,2).”
BackgroundInfluentialSelf-citationSaboor Aftab, S. A., Kumar, S., & Barber, T. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12092 · Cited by 157
Role of reactive nitrogen species in male infertility
Doshi, S., Khullar, K., Sharma, R. K., & Agarwal, A. K. (2012) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-10-109 · Cited by 171
“This NO-mediated chain reaction is known as lipid peroxidation [15,16,51-53].”
BackgroundSurampudi, P. N., Wang, C., & Swerdloff, R. S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/625434 · Cited by 170
“A levels in subjects with metabolic syndrome and or T2DM [105, 140].”
BackgroundInfluentialRisks and benefits of testosterone therapy in older men
Spitzer, M., Huang, G., Basaria, S., Travison, T. G., & Bhasin, S. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.73 · Cited by 154
Vikan, T., Schirmer, H., Njølstad, I., & Svartberg, J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0943 · Cited by 151
Aging and sex hormones in males
Decaroli, M. C., & Rochira, V. (2016) · Virulence · doi:10.1080/21505594.2016.1259053 · Cited by 157
The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health
Alemany, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911952 · Cited by 174
Metabolic Disorders and Male Hypogonadotropic Hypogonadism
Pivonello, R., Menafra, D., Riccio, E., Garifalos, F., Mazzella, M., de Angelis, C., & Colao, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00345 · Cited by 161
“Moreover, additional studies highlighted that the association of testosterone deficiency with metabolic disorders frequently occurs in a clinical context of Hypo-H, and that Hypo-H is frequently reported in metabolic disorders, such as obesity, IR, MetS, and T2-DM (15, 19, 20).”
BackgroundResultInfluentialTestosterone Concentration in Young Patients With Diabetes
Chandel, A., Dhindsa, S., Topiwala, S., Chaudhuri, A., & Dandona, P. (2008) · Diabetes Care · doi:10.2337/dc08-0851 · Cited by 160
“W e have previously shown that patients with type 2 diabetes have a frequent occurrence of hypogonadotrophic hypogonadism, as reflected in low plasma concentrations of testosterone and inappropriately low luteinizing hormone (LH) and follicle-stimulating hormone (FSH) (1).”
BackgroundResultSelf-citationOutcomes of clomiphene citrate treatment in young hypogonadal men
Katz, D. J., Nabulsi, O., Tal, R., & Mulhall, J. P. (2012) · BJU International · doi:10.1111/j.1464-410x.2011.10702.x · Cited by 142
Male hypogonadism: Symptoms and treatment
Kumar, P., Kumar, N., Thakur, D., & Patidar, A. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.72420 · Cited by 142
“Although diabetes mellitus–related hypogonadism was previously thought to be associated with testicular failure, study results show one-third of diabetic men had low testosterone levels, but also had low pituitary hormone levels.[10] Population projections expect the number of cases of diabetes mellitus to rise from 1…”
BackgroundZhang, X., Filippi, S., Morelli, A., Vignozzi, L., Luconi, M., Donati, S., Forti, G., & Maggi, M. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00207.x · Cited by 138
Obesity, low testosterone levels and erectile dysfunction
Diaz‐Arjonilla, M., Schwarcz, M. G., Swerdloff, R. S., & Wang, C. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.42 · Cited by 153
Obesity and male hypogonadism: Tales of a vicious cycle
Carrageta, D. F., Oliveira, P. F., Alves, M. G., & Monteiro, M. P. (2019) · Obesity Reviews · doi:10.1111/obr.12863 · Cited by 138
“In addition, other obesity‐related comorbidities, such as type 2 diabetes mellitus and metabolic syndrome, are also directly associated with male hypogonadism.(40,41) Moreover, evidence also alerts for a bidirectional relationship, as hypogonadism per se can lead to increased adiposity, while obesity can also be the c…”
BackgroundHormone Replacement Therapy and Physical Function in Healthy Older Men. Time to Talk Hormones?
Giannoulis, M. G., Martin, F. C., Nair, K. S., Umpleby, A. M., & Sonksen, P. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1002 · Cited by 132
Calculation of Bioavailable and Free Testosterone in Men: A Comparison of 5 Published Algorithms
de Ronde, W., van der Schouw, Y. T., Pols, H. A., Gooren, L. J., Muller, M., Grobbee, D. E., & de Jong, F. H. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063354 · Cited by 131
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
“As shown in Figure 1B, HbA1c levels were significantly reduced in the Tgroup, and the reduced values were maintained with TTh over the course of follow-up.”
ResultInfluentialCorona, G., Monami, M., Boddi, V., Cameron-Smith, M., Fisher, A. D., De Vita, G., Melani, C., Balzi, D., Sforza, A., Forti, G., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01690.x · Cited by 128
Low Estradiol Concentrations in Men With Subnormal Testosterone Concentrations and Type 2 Diabetes
Dhindsa, S., Furlanetto, R. W., Vora, M., Ghanim, H., Chaudhuri, A., & Dandona, P. (2011) · Diabetes Care · doi:10.2337/dc11-0208 · Cited by 135
“However,wehavepreviously shown and confirmed again that HbA1c, medications, or the duration of type 2 diabetes do not appear to affect gonadal status in patients with type 2 diabetes (1).”
BackgroundSelf-citationSubstantially increased risk of cancer in patients with diabetes mellitus
Noto, H., Osame, K., Sasazuki, T., & Noda, M. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.06.004 · Cited by 136
Hypogonadism and metabolic syndrome.
(2011) · PubMed · doi:10.3275/7806 · Cited by 125
Williams, G. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.017 · Cited by 123
Bhatia, V., Chaudhuri, A., Tomar, R., Dhindsa, S., Ghanim, H., & Dandona, P. (2006) · Diabetes Care · doi:10.2337/dc06-0637 · Cited by 127
Self-citationTestosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
Stanworth, R. D., & Jones, T. H. (2008) · Frontiers of hormone research · doi:10.1159/000176046 · Cited by 122
The Relationship between Testosterone Deficiency and Men's Health
Tsujimura, A. (2013) · The World Journal of Men s Health · doi:10.5534/wjmh.2013.31.2.126 · Cited by 143
Wang, K., Cai, X., Tian, Y., Wu, T., Cao, C., & Li, H. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122346 · Cited by 118
Hypothesis: Kisspeptin Mediates Male Hypogonadism in Obesity and Type 2 Diabetes
George, J. T., Millar, R. P., & Anderson, R. A. (2010) · Neuroendocrinology · doi:10.1159/000299767 · Cited by 123
“In men with established T2DM, decreased plasma-free testosterone is found in a third to half of all patients [”
BackgroundGiagulli, V. A., Carbone, M. D., Ramunni, M. I., Licchelli, B., De Pergola, G., Sabbà, C., Guastamacchia, E., & Triggiani, V. (2015) · Andrology · doi:10.1111/andr.12099 · Cited by 109
Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.007 · Cited by 118
Which patients with sexual dysfunction are suitable for testosterone replacement therapy?
Morelli, A., Corona, G., Filippi, S., Ambrosini, S., Forti, G., Vignozzi, L., & Maggi, M. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349232 · Cited by 109
Testosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Singh, P. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123552 · Cited by 117
Greco, E. A., Spera, G., & Aversa, A. (2006) · European Urology · doi:10.1016/j.eururo.2006.06.049 · Cited by 109
“A high prevalence of ED in patients with diabetes has been attributed mainly to vascular and neurologic conditions, but also to hypogonadism [51], which has been observed to occur commonly with type II diabetes [52] and to result from metabolic syndrome in middle-aged men [53].”
BackgroundKlinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition
Bojesen, A., Host, C., & Gravholt, C. H. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq016 · Cited by 111
Corona, G., Forti, G., & Maggi, M. (2008) · The Aging Male · doi:10.1080/13685530802468497 · Cited by 111
Cheung, K. K. T., Luk, A. O. Y., So, W. Y., Ronald, C. W., Kong, A. P. S., Chow, F. C. C., & Chan, J. C. N. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12288 · Cited by 117
MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview
Diamanti‐Kandarakis, E., Dattilo, M., Μacut, D., Duntas, L. H., Gonos, E. S., Goulis, D. G., Kanaka‐Gantenbein, C., Καπετάνου, Μ., Koukkou, E. G., Lambrinoudaki, I. V., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1061 · Cited by 117
George, J. T., Veldhuis, J. D., Tena‐Sempere, M., Millar, R. P., & Anderson, R. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12103 · Cited by 105
Testosterone and glucose metabolism in men: current concepts and controversies
Grossmann, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0393 · Cited by 113
“In men with diabetes, free testosterone, if measured by gold standard equilibrium dialysis (Dhindsa et al. 2004), is reduced.”
BackgroundPrevalence of endocrine disorders in obese patients: systematic review and meta-analysis
van Hulsteijn, L. T., Pasquali, R., Casanueva, F., Haluzik, M., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0666 · Cited by 103
Haider, A., Yassin, A. A., Doros, G. D., & Saad, F. (2014) · International Journal of Endocrinology · doi:10.1155/2014/683515 · Cited by 111
“The proportion ofmen with TDwas increased inmen with T2DM [79].”
BackgroundKızılay, F., Gali, H. E., & Şerefoğlu, E. C. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.07.002 · Cited by 101
“Testosterone concentrations tend to decrease in association with low levels of luteinizing hormone and folliclestimulating hormone.(34) Testosterone is the hormone that affects sexual desire in men and women(35) and DM decreases libido by lowering testosterone levels.”
BackgroundContrasting testosterone concentrations in type 1 and type 2 diabetes.
Tomar, R., Dhindsa, S., Chaudhuri, A., Mohanty, P., Garg, R., & Dandona, P. (2006) · Diabetes Care · doi:10.2337/dc06-0197 · Cited by 100
Self-citationUsui, T., Kajita, K., Kajita, T., Mori, I., Hanamoto, T., Ikeda, T., Okada, H., Taguchi, K., Kitada, Y., Morita, H., et al. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.051 · Cited by 100
“Moreover, hypogonadotropic hypogonadism occurs commonly in type 2 diabetes [15].”
BackgroundDiabetes mellitus is associated with subnormal serum levels of free testosterone in men
Rhoden, E. L., Ribeiro, E. P., Teloken, C., & Souto, C. A. V. (2005) · BJU International · doi:10.1111/j.1464-410x.2005.05728.x · Cited by 100
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 110
“This supports the known association of type 2 diabetes and metabolic syndrome with low gonadotrophins [Dhindsa et al. 2004] and various reports of enhanced luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone secretion in (generally obese) men with aromatase inhibitors”
Background
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.